Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Brentuximab_vedotin> ?p ?o. }
Showing items 1 to 67 of
67
with 100 items per page.
- Brentuximab_vedotin abstract "Brentuximab vedotin (INN, trade name Adcetris) is an antibody-drug conjugate (ADC) directed to the protein CD30, which is expressed in classical Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (sALCL).On 28 February 2011 Seattle Genetics submitted a Biologics License Application or BLA to the U.S. Food and Drug Administration (FDA) for the use of brentuximab vedotin in relapsed or refractory Hodgkin's lymphoma and relapsed or refractory systemic anaplastic large cell lymphoma.The drug was granted accelerated approval by the U.S. Food and Drug Administration on August 19, 2011 for relapsed HL and relapsed sALCL and conditional Marketing authorization from the European Medicines Agency in October 2012 for relapsed or refractory HL and relapsed or refractory sALCL.".
- Brentuximab_vedotin atcPrefix "L01".
- Brentuximab_vedotin atcSuffix "XC12".
- Brentuximab_vedotin casNumber "914088-09-8".
- Brentuximab_vedotin fdaUniiCode "7XL5ISS668".
- Brentuximab_vedotin thumbnail MMAE-MAB-conjugate_skeletal.svg?width=300.
- Brentuximab_vedotin wikiPageID "24950940".
- Brentuximab_vedotin wikiPageRevisionID "599839545".
- Brentuximab_vedotin atcPrefix "L01".
- Brentuximab_vedotin atcSuffix "XC12".
- Brentuximab_vedotin casNumber "914088".
- Brentuximab_vedotin chemicalFormula "C6476H9930N1690O2030S40 3–5".
- Brentuximab_vedotin chemspiderid "NA".
- Brentuximab_vedotin hasPhotoCollection Brentuximab_vedotin.
- Brentuximab_vedotin legalUs "Rx-only".
- Brentuximab_vedotin licenceUs "Brentuximab".
- Brentuximab_vedotin mabType "mab".
- Brentuximab_vedotin molecularWeight "149.2".
- Brentuximab_vedotin pregnancyUs "D".
- Brentuximab_vedotin routesOfAdministration "Intravenous".
- Brentuximab_vedotin source "xi/o".
- Brentuximab_vedotin synonyms "SGN-35, previously cAC10-vcMMAE".
- Brentuximab_vedotin target CD30.
- Brentuximab_vedotin tradename "Adcetris".
- Brentuximab_vedotin type "mab".
- Brentuximab_vedotin unii "7".
- Brentuximab_vedotin verifiedfields "changed".
- Brentuximab_vedotin verifiedrevid "458639365".
- Brentuximab_vedotin watchedfields "changed".
- Brentuximab_vedotin subject Category:Monoclonal_antibodies.
- Brentuximab_vedotin type Abstraction100002137.
- Brentuximab_vedotin type Antibody115027189.
- Brentuximab_vedotin type Chemical114806838.
- Brentuximab_vedotin type Compound114818238.
- Brentuximab_vedotin type Macromolecule114944888.
- Brentuximab_vedotin type Material114580897.
- Brentuximab_vedotin type Matter100020827.
- Brentuximab_vedotin type Molecule114682133.
- Brentuximab_vedotin type MonoclonalAntibodies.
- Brentuximab_vedotin type MonoclonalAntibody115029781.
- Brentuximab_vedotin type OrganicCompound114727670.
- Brentuximab_vedotin type Part113809207.
- Brentuximab_vedotin type PhysicalEntity100001930.
- Brentuximab_vedotin type Protein114728724.
- Brentuximab_vedotin type Relation100031921.
- Brentuximab_vedotin type Substance100019613.
- Brentuximab_vedotin type Thing100002452.
- Brentuximab_vedotin type Unit109465459.
- Brentuximab_vedotin type Drug.
- Brentuximab_vedotin type DrugProduct.
- Brentuximab_vedotin type FunctionalSubstance.
- Brentuximab_vedotin comment "Brentuximab vedotin (INN, trade name Adcetris) is an antibody-drug conjugate (ADC) directed to the protein CD30, which is expressed in classical Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (sALCL).On 28 February 2011 Seattle Genetics submitted a Biologics License Application or BLA to the U.S.".
- Brentuximab_vedotin label "Brentuximab vedotin".
- Brentuximab_vedotin label "Brentuximab vedotin".
- Brentuximab_vedotin label "Brentuximab".
- Brentuximab_vedotin label "برنتوكسيماب فيدوتين".
- Brentuximab_vedotin label "ブレンツキシマブ ベドチン".
- Brentuximab_vedotin sameAs Brentuximab.
- Brentuximab_vedotin sameAs Brentuximab_vedotin.
- Brentuximab_vedotin sameAs ブレンツキシマブ_ベドチン.
- Brentuximab_vedotin sameAs m.09gh_sb.
- Brentuximab_vedotin sameAs Q422324.
- Brentuximab_vedotin sameAs Q422324.
- Brentuximab_vedotin sameAs Brentuximab_vedotin.
- Brentuximab_vedotin wasDerivedFrom Brentuximab_vedotin?oldid=599839545.
- Brentuximab_vedotin depiction MMAE-MAB-conjugate_skeletal.svg.
- Brentuximab_vedotin isPrimaryTopicOf Brentuximab_vedotin.
